CLINICAL_TRIALS
trial_result
· 2015-02-11
Clinical Trial Update: Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) [Phase 4]
Summary
Phase 4 trial evaluating sorafenib dose ramp-up in hepatocellular carcinoma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2015-02-11